MovDisordV3, Main, Merge, bibRecord, 008220

A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients

Identifieur interne : 008220 ( Main/Merge ); précédent : 008219; suivant : 008221

A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients

Auteurs : R. A. Hauser [États-Unis] ; E. Molho [États-Unis] ; H. Shale [États-Unis] ; S. Pedder [États-Unis] ; E. E. Dorflinger [États-Unis]

Source :

Movement disorders [ 0885-3185 ] ; 1998.

RBID : Pascal:98-0354367

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Motricité, Tolcapone, Chimiothérapie, Antiparkinsonien, Inhibiteur enzyme, Catechol O-methyltransferase, Voie orale, Sélégiline, IMAO B, Diarrhée, Nausée, Randomisation, Traitement, Toxicité, Association médicamenteuse, Adulte, Etude double insu.
Wicri :
- topic : Adulte.

English descriptors

KwdEn :
- Adult, Antiparkinson agent, Catechol O-methyltransferase, Chemotherapy, Diarrhea, Double blind study, Drug combination, Enzyme inhibitor, MAO B inhibitor, Motricity, Nausea, Oral administration, Parkinson disease, Randomization, Selegiline, Tolcapone, Toxicity, Treatment.

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 002F64
to stream PascalFrancis, to step Curation: 003860
to stream PascalFrancis, to step Checkpoint: 003096

Links to Exploration step

Pascal:98-0354367

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients</title>
<author><name sortKey="Hauser, R A" sort="Hauser, R A" uniqKey="Hauser R" first="R. A." last="Hauser">R. A. Hauser</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>University of South Florida</s1>
<s2>Tampa, Florida</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Floride</region>
<settlement type="city">Tampa</settlement>
</placeName>
<orgName type="university">Université de Floride du Sud</orgName>
</affiliation>
</author>
<author><name sortKey="Molho, E" sort="Molho, E" uniqKey="Molho E" first="E." last="Molho">E. Molho</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Albany Medical College</s1>
<s2>Albany, New York</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shale, H" sort="Shale, H" uniqKey="Shale H" first="H." last="Shale">H. Shale</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>East Bay Neurology</s1>
<s2>Berkeley, California</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pedder, S" sort="Pedder, S" uniqKey="Pedder S" first="S." last="Pedder">S. Pedder</name>
<affiliation wicri:level="2"><inist:fA14 i1="04"><s1>Hoffmann-La Roche</s1>
<s2>Nutley, New Jersey</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dorflinger, E E" sort="Dorflinger, E E" uniqKey="Dorflinger E" first="E. E." last="Dorflinger">E. E. Dorflinger</name>
<affiliation wicri:level="2"><inist:fA14 i1="04"><s1>Hoffmann-La Roche</s1>
<s2>Nutley, New Jersey</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">98-0354367</idno>
<date when="1998">1998</date>
<idno type="stanalyst">PASCAL 98-0354367 INIST</idno>
<idno type="RBID">Pascal:98-0354367</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002F64</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003860</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">003096</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Hauser R:a:pilot:evaluation</idno>
<idno type="wicri:Area/Main/Merge">008220</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients</title>
<author><name sortKey="Hauser, R A" sort="Hauser, R A" uniqKey="Hauser R" first="R. A." last="Hauser">R. A. Hauser</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>University of South Florida</s1>
<s2>Tampa, Florida</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Floride</region>
<settlement type="city">Tampa</settlement>
</placeName>
<orgName type="university">Université de Floride du Sud</orgName>
</affiliation>
</author>
<author><name sortKey="Molho, E" sort="Molho, E" uniqKey="Molho E" first="E." last="Molho">E. Molho</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Albany Medical College</s1>
<s2>Albany, New York</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shale, H" sort="Shale, H" uniqKey="Shale H" first="H." last="Shale">H. Shale</name>
<affiliation wicri:level="2"><inist:fA14 i1="03"><s1>East Bay Neurology</s1>
<s2>Berkeley, California</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pedder, S" sort="Pedder, S" uniqKey="Pedder S" first="S." last="Pedder">S. Pedder</name>
<affiliation wicri:level="2"><inist:fA14 i1="04"><s1>Hoffmann-La Roche</s1>
<s2>Nutley, New Jersey</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dorflinger, E E" sort="Dorflinger, E E" uniqKey="Dorflinger E" first="E. E." last="Dorflinger">E. E. Dorflinger</name>
<affiliation wicri:level="2"><inist:fA14 i1="04"><s1>Hoffmann-La Roche</s1>
<s2>Nutley, New Jersey</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1998">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antiparkinson agent</term>
<term>Catechol O-methyltransferase</term>
<term>Chemotherapy</term>
<term>Diarrhea</term>
<term>Double blind study</term>
<term>Drug combination</term>
<term>Enzyme inhibitor</term>
<term>MAO B inhibitor</term>
<term>Motricity</term>
<term>Nausea</term>
<term>Oral administration</term>
<term>Parkinson disease</term>
<term>Randomization</term>
<term>Selegiline</term>
<term>Tolcapone</term>
<term>Toxicity</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Motricité</term>
<term>Tolcapone</term>
<term>Chimiothérapie</term>
<term>Antiparkinsonien</term>
<term>Inhibiteur enzyme</term>
<term>Catechol O-methyltransferase</term>
<term>Voie orale</term>
<term>Sélégiline</term>
<term>IMAO B</term>
<term>Diarrhée</term>
<term>Nausée</term>
<term>Randomisation</term>
<term>Traitement</term>
<term>Toxicité</term>
<term>Association médicamenteuse</term>
<term>Adulte</term>
<term>Etude double insu</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Adulte</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
<li>Floride</li>
<li>New Jersey</li>
<li>État de New York</li>
</region>
<settlement><li>Tampa</li>
</settlement>
<orgName><li>Université de Floride du Sud</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Floride"><name sortKey="Hauser, R A" sort="Hauser, R A" uniqKey="Hauser R" first="R. A." last="Hauser">R. A. Hauser</name>
</region>
<name sortKey="Dorflinger, E E" sort="Dorflinger, E E" uniqKey="Dorflinger E" first="E. E." last="Dorflinger">E. E. Dorflinger</name>
<name sortKey="Molho, E" sort="Molho, E" uniqKey="Molho E" first="E." last="Molho">E. Molho</name>
<name sortKey="Pedder, S" sort="Pedder, S" uniqKey="Pedder S" first="S." last="Pedder">S. Pedder</name>
<name sortKey="Shale, H" sort="Shale, H" uniqKey="Shale H" first="H." last="Shale">H. Shale</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008220 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 008220 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     Pascal:98-0354367
   |texte=   A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients

A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri